Cargando…
Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial
OBJECTIVE: Intensive insulin therapy (IIT) reduces morbidity and mortality in patients in surgical intensive care units. The aim of this study is to assess the effect of IIT using a closed-loop system in hepatectomized patients. RESEARCH DESIGN AND METHODS: Patients were randomly assigned to receive...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713620/ https://www.ncbi.nlm.nih.gov/pubmed/19435954 http://dx.doi.org/10.2337/dc08-2107 |
_version_ | 1782169588745633792 |
---|---|
author | Okabayashi, Takehiro Nishimori, Isao Maeda, Hiromichi Yamashita, Koichi Yatabe, Tomoaki Hanazaki, Kazuhiro |
author_facet | Okabayashi, Takehiro Nishimori, Isao Maeda, Hiromichi Yamashita, Koichi Yatabe, Tomoaki Hanazaki, Kazuhiro |
author_sort | Okabayashi, Takehiro |
collection | PubMed |
description | OBJECTIVE: Intensive insulin therapy (IIT) reduces morbidity and mortality in patients in surgical intensive care units. The aim of this study is to assess the effect of IIT using a closed-loop system in hepatectomized patients. RESEARCH DESIGN AND METHODS: Patients were randomly assigned to receive IIT using a closed-loop system: an artificial pancreas (AP group) or conventional insulin therapy using the sliding-scale method (SS group). RESULTS: The incidence of surgical-site infection in the AP group was significantly lower than that in the SS group. The length of hospitalization required for patients in the AP group was significantly shorter than that in the SS group. CONCLUSIONS: Total hospital costs for patients in the AP group were significantly lower than for patients in the SS group. IIT using a closed-loop system maintained near-normoglycemia and contributed to a reduction in the incidence of SSI and total hospital costs due to shortened hospitalization. |
format | Text |
id | pubmed-2713620 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-27136202010-08-01 Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial Okabayashi, Takehiro Nishimori, Isao Maeda, Hiromichi Yamashita, Koichi Yatabe, Tomoaki Hanazaki, Kazuhiro Diabetes Care Original Research OBJECTIVE: Intensive insulin therapy (IIT) reduces morbidity and mortality in patients in surgical intensive care units. The aim of this study is to assess the effect of IIT using a closed-loop system in hepatectomized patients. RESEARCH DESIGN AND METHODS: Patients were randomly assigned to receive IIT using a closed-loop system: an artificial pancreas (AP group) or conventional insulin therapy using the sliding-scale method (SS group). RESULTS: The incidence of surgical-site infection in the AP group was significantly lower than that in the SS group. The length of hospitalization required for patients in the AP group was significantly shorter than that in the SS group. CONCLUSIONS: Total hospital costs for patients in the AP group were significantly lower than for patients in the SS group. IIT using a closed-loop system maintained near-normoglycemia and contributed to a reduction in the incidence of SSI and total hospital costs due to shortened hospitalization. American Diabetes Association 2009-08 2009-05-12 /pmc/articles/PMC2713620/ /pubmed/19435954 http://dx.doi.org/10.2337/dc08-2107 Text en © 2009 by the American Diabetes Association. https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) for details. |
spellingShingle | Original Research Okabayashi, Takehiro Nishimori, Isao Maeda, Hiromichi Yamashita, Koichi Yatabe, Tomoaki Hanazaki, Kazuhiro Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial |
title | Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial |
title_full | Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial |
title_fullStr | Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial |
title_full_unstemmed | Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial |
title_short | Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial |
title_sort | effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713620/ https://www.ncbi.nlm.nih.gov/pubmed/19435954 http://dx.doi.org/10.2337/dc08-2107 |
work_keys_str_mv | AT okabayashitakehiro effectofintensiveinsulintherapyusingaclosedloopglycemiccontrolsysteminhepaticresectionpatientsaprospectiverandomizedclinicaltrial AT nishimoriisao effectofintensiveinsulintherapyusingaclosedloopglycemiccontrolsysteminhepaticresectionpatientsaprospectiverandomizedclinicaltrial AT maedahiromichi effectofintensiveinsulintherapyusingaclosedloopglycemiccontrolsysteminhepaticresectionpatientsaprospectiverandomizedclinicaltrial AT yamashitakoichi effectofintensiveinsulintherapyusingaclosedloopglycemiccontrolsysteminhepaticresectionpatientsaprospectiverandomizedclinicaltrial AT yatabetomoaki effectofintensiveinsulintherapyusingaclosedloopglycemiccontrolsysteminhepaticresectionpatientsaprospectiverandomizedclinicaltrial AT hanazakikazuhiro effectofintensiveinsulintherapyusingaclosedloopglycemiccontrolsysteminhepaticresectionpatientsaprospectiverandomizedclinicaltrial |